New Plant-Infused cream aims to heal Incontinence-Related skin damage

NCT ID NCT06370637

Not yet recruiting Symptom relief Sponsor: Scotiaderm Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new barrier cream (Dermategrity Everyday Barrier Cream) that combines zinc oxide with a natural plant extract to heal skin damage caused by fecal incontinence. The cream is designed to protect the skin and block harmful enzymes from stool. Researchers will compare it to a standard zinc oxide cream in 40 adults over 14 days, measuring healing and symptom relief.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Dermategrity Everyday Barrier Cream (zinc oxide plus plant extract)
What this could lead to: If it works, this cream could offer a more effective way to heal skin damage caused by fecal incontinence, improving comfort and quality of life.
What could go wrong: This is a small, early-stage trial with only 40 participants, so results may not apply to everyone. The cream is not a treatment for incontinence itself, and individual results may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FECAL INCONTINENCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Fecal Incontinence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FECAL INCONTINENCE INCONTINENCE ASSOCIATED DERMATITIS MOISTURE ASSOCIATED SKIN DAMAGE

Contacts and locations

Locations

University of Calgary Cumming School of Medicine

Calgary, Alberta, T2N 2T8, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.